
Sign up to save your podcasts
Or


The ASX200 is eyeing a flat open today with all eyes and ears on the U.S. presidential debate kicking off at 11am AEDT.
The first COVID-19 treatment was approved by the U.S. FDA, giving Gilead Sciences’ drug, Remdesivir, formal approval to treat COVID-19.
What to watch today:
Trading ideas:
By Bell DirectThe ASX200 is eyeing a flat open today with all eyes and ears on the U.S. presidential debate kicking off at 11am AEDT.
The first COVID-19 treatment was approved by the U.S. FDA, giving Gilead Sciences’ drug, Remdesivir, formal approval to treat COVID-19.
What to watch today:
Trading ideas:

15 Listeners

91 Listeners

15 Listeners

6 Listeners

10 Listeners

63 Listeners

19 Listeners

5 Listeners

7 Listeners

1 Listeners

6 Listeners

1 Listeners

3 Listeners

1 Listeners

0 Listeners